Literature DB >> 34115941

The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19.

Matsuo So1, Hiroki Kabata2, Mai Takahashi1, Natalia N Egorova3, Toshiki Kuno1.   

Abstract

Entities:  

Year:  2021        PMID： 34115941     DOI： 10.1089/jamp.2021.0020

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN： 1941-2711            Impact factor:   2.849


× No keyword cloud information.
  6 in total

Review 1.  Prediction of in-hospital mortality with machine learning for COVID-19 patients treated with steroid and remdesivir.

Authors:  Toshiki Kuno; Yuki Sahashi; Shinpei Kawahito; Mai Takahashi; Masao Iwagami; Natalia N Egorova
Journal:  J Med Virol       Date:  2021-10-22       Impact factor: 20.693

2.  The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroids.

Authors:  Matsuo So; Mai Takahashi; Yoshihisa Miyamoto; Yoshiko Ishisaka; Masao Iwagami; Yusuke Tsugawa; Natalia N Egorova; Toshiki Kuno
Journal:  Diabetes Metab Syndr       Date:  2021-12-29

3.  The association between famotidine and in-hospital mortality of patients with COVID-19.

Authors:  Toshiki Kuno; Matsuo So; Mai Takahashi; Natalia N Egorova
Journal:  J Med Virol       Date:  2021-10-11       Impact factor: 20.693

4.  The association of statins use with survival of patients with COVID-19.

Authors:  Toshiki Kuno; Matsuo So; Masao Iwagami; Mai Takahashi; Natalia N Egorova
Journal:  J Cardiol       Date:  2021-12-22       Impact factor: 3.159

5.  Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid.

Authors:  Toshiki Kuno; Matsuo So; Mai Takahashi; Natalia N Egorova
Journal:  J Thromb Thrombolysis       Date:  2021-09-15       Impact factor: 5.221

6.  The association of anticoagulation before admission and survival of patients with COVID-19.

Authors:  Toshiki Kuno; Mai Takahashi; Matsuo So; Natalia N Egorova
Journal:  J Cardiol       Date:  2021-12-16       Impact factor: 3.159
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.